吉林敖东发布市值提升计划 聚焦主业发展与股东价值回报

Core Viewpoint - Jilin Aodong (000623) has announced a comprehensive market value enhancement plan focusing on five core initiatives to align investment value with intrinsic quality, boost market confidence, and achieve high-quality development [1] Group 1: Focus on Pharmaceutical Main Business - The company aims to strengthen its pharmaceutical manufacturing sector, covering traditional Chinese medicine, chemical drugs, and health products, while enhancing the entire industry chain [2] - Future strategies include focusing on "authentic medicinal materials," "quality control," and "intelligent manufacturing" to upgrade the traditional Chinese medicine industry [2] Group 2: Optimizing Shareholder Returns - Jilin Aodong will initiate a mid-term dividend for the first time in 2024, with a proposed annual dividend of 3 yuan per share, totaling 5.91 billion yuan in cash dividends for the year [3] - Cumulatively, from 2022 to 2024, the total cash dividends and share buybacks will amount to 23.67 billion yuan, representing 148.16% of the average net profit over the last three accounting years [3] Group 3: Strengthening Management Confidence - The management team, including the chairman and vice-chairman, has demonstrated confidence in the company's future by purchasing 136.27 million shares for a total of 18.50 million yuan [4] - Active participation in performance briefings and investor communication meetings has been emphasized to enhance market understanding of the company's value [4] Group 4: Share Buybacks to Enhance Value - The company has conducted three share buybacks totaling 720 million yuan, repurchasing 45.17 million shares to optimize capital structure and enhance earnings per share [5] - A new buyback plan for 2024 has been initiated, with 420 million yuan allocated to repurchase 23.51 million shares, reinforcing shareholder rights [5] Group 5: Improving Information Disclosure and Investor Communication - Jilin Aodong has maintained an "A" rating for information disclosure for ten consecutive years, ensuring accurate and complete communication with investors through various channels [6] - The company plans to continue enhancing its core competitiveness through innovation and market-oriented reforms, aiming for sustainable long-term returns for investors [6]